ArticleMaterials today. Bio2026
Melatonin rhythm-mimicking smart hydrogel for circadian clock regulation and promotion of intervertebral disc regeneration.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intervertebral disc degeneration (IVDD) is a leading cause of low back pain, with growing evidence suggesting a connection between its pathogenesis and circadian rhythm disruption. This study investigated the link between circadian regulation and IVDD by integrating epidemiological evidence from the UK Biobank cohort (n = 287,150), Mendelian randomization analysis, and multi-species validation using Bmal1 knockout mice and human and rat disc samples. Core circadian clock proteins were significantly downregulated in degenerated intervertebral disc tissues across species. To counteract this, a composite hydrogel was developed for the cyclic delivery of melatonin, which effectively upregulated BMAL1 and CLOCK protein expression, restored circadian rhythm, and enhanced extracellular matrix (ECM) synthesis. When implanted into degenerated rat discs, the hydrogel alleviated IVDD by reestablishing circadian homeostasis. These findings highlight cyclic melatonin delivery as a promising therapeutic approach for IVDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.